TFS Capital’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-20,974
| Closed | -$65K | – | 987 |
|
|
2016
Q3 | $65K | Buy |
+20,974
| New | +$65K | 0.02% | 696 |
|
|
2016
Q1 | – | Sell |
-34,306
| Closed | -$138K | – | 1173 |
|
|
2015
Q4 | $138K | Buy |
34,306
+24,115
| +237% | +$97K | 0.01% | 624 |
|
|
2015
Q3 | $47K | Sell |
10,191
-826
| -7% | -$3.81K | ﹤0.01% | 847 |
|
|
2015
Q2 | $57K | Sell |
11,017
-36,705
| -77% | -$190K | 0.01% | 850 |
|
|
2015
Q1 | $299K | Sell |
47,722
-2,681
| -5% | -$16.8K | 0.03% | 685 |
|
|
2014
Q4 | $317K | Buy |
50,403
+33,960
| +207% | +$214K | 0.03% | 714 |
|
|
2014
Q3 | $100K | Buy |
16,443
+1,851
| +13% | +$11.3K | 0.01% | 970 |
|
|
2014
Q2 | $96K | Buy |
+14,592
| New | +$96K | 0.01% | 1053 |
|
|
2013
Q3 | – | Sell |
-86,516
| Closed | -$1.14M | – | 1726 |
|
|
2013
Q2 | $1.14M | Buy |
+86,516
| New | +$1.14M | 0.05% | 554 |
|